Professor
Stanford University
Dr. Maria Grazia Roncarolo is George D. Smith Professor in Stem Cell and Regenerative Medicine, Professor of Pediatrics and of Medicine at Stanford School of Medicine. She co-directs the Institute for Stem Cell Biology and Regenerative Medicine and directs the Center for Definitive and Curative Medicine (CDCM) that aims to bridge the divide between laboratory discovery and translation to patients in stem cell and gene therapy.
She is an internationally renowned pediatric immunologist who has made seminal contributions to translational research in immunology and gene therapy. Her research studies have led to a greater understanding of the mechanisms underlying immune tolerance and have been of paramount importance to the development of novel cell and gene therapies for patients with genetic and acquired diseases of the hematopoietic and immune systems. Dr. Roncarolo has been the principal investigator for several stem cell and gene therapy trials, including the trial for Severe Combined Immunodeficiency (SCID) patients lacking adenosine deaminase (ADA), which led to European market authorization of Strimvelis.
In 2010 Dr. Roncarolo received the “Outstanding Achievement Award” from the European Society of Gence and Cell Therapy (ESGCT) for outstanding career and pioneering contributions to the field and in 2017 the “Outstanding Achievement Award” from the American Society of Gene & Cell Therapy (ASGCT) for a lifetime of significant scientific contributions to the field of gene and cell therapy.
